Patents Assigned to VDF Futureceuticals
  • Low-mycotoxin coffee cherry products
    Patent number: 9888702
    Abstract: A coffee cherry is harvested, preferably in a sub-ripe state, and quick-dried to provide a basis for numerous nutritional products. Such coffee cherries and portions thereof may be particularly characterized by their extremely low concentration of mycotoxins, including various aflatoxins, fumonisins, ochratoxins, and/or vomitoxin (DON, deoxynivalenol).
    Type: Grant
    Filed: July 1, 2015
    Date of Patent: February 13, 2018
    Assignee: VDF Futureceuticals
    Inventors: Dusan Miljkovic, Brad Duell, Vukosava Miljkovic